ADAMs: Focus on the protease domain

Current Opinion in Cell Biology

Volumn 10, Issue 5, 1998, Pages 654-659

  Black, Roy A ^a   White, Judith M ^b  

^a AMGEN INC   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISINTEGRIN; METALLOPROTEINASE; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; CRYSTAL STRUCTURE; ENZYME STRUCTURE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031698581     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80042-2     Document Type: Article

References (41)

1. Wolfsberg TG, White JM. ADAMs in fertilization and development. Dev Biol. 180:1996;389-401.
2. Almeida EAC, Huovila A-PJ, Sutherland AE, Stephens LE, Calarco PG, Shaw LM, Mercurio AM, Sonnenberg A, Primakoff P, Myles DG, White JM. Mouse egg integrin α6β1 functions as a sperm receptor. Cell. 81:1995;1095-1104.
3. Zhang X-P, Kamata T, Yokoyama K, Puzon-McLaughlin W, Takada Y. Specific interaction of the recombinant disintegrin-like domain of MDC-15 (Metargidin, ADAM-15) with integrin αvβ3. of special interest J Biol Chem. 273:1998;7345-7350 This paper provides the first demonstration of direct binding of a recombinant ADAM disintegrin domain to a specific integrin and demonstration of sequence requirements for integrin specificity.
4. Blobel CP. Metalloproteinase-disintegrins: links to cell adhesion and cleavage of TNFα and notch. Cell. 90:1997;589-592.
5. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:1997;439-442.
6. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB, Bode W. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4:1995;823-840.
7. Black R. TNF-α converting enzyme. Barrett AJ, Rawlings ND, Woessner JF. Handbook of Proteolytic Enzymes. 1998;1315-1317 Academic Press, London.
8. Wolfsberg TG, White JM. ADAM metalloproteinases. Barrett AJ, Rawlings ND, Woessner JF. Handbook of Proteolytic Enzymes. 1998;1310-1313 Academic Press, London.
9. Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM. Human ADAM 12 (meltrin alpha) is an active metalloprotease. J Biol Chem. 273:1998;16993-16997.
10. Pan D, Rubin GM. Kuzbanian controls proteolytic processing of notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. of outstanding interest Cell. 90:1997;271-280 The authors demonstrate a requirement for the KUZ protease domain in neural development and in NOTCH cleavage.
11. Rooke J, Pan D, Xu T, Rubin GM. KUZ, a conserved metalloproteinase-disintegrin protein with two roles in Drosophila neurogenesis. of outstanding interest Science. 273:1996;1227-1231 This paper presents the sequence of KUZ and the phenotype of KUZ-null cells in Drosophila. It provides the first evidence of a role for KUZ in lateral inhibtion.
12. Sotillos S, Roch F, Campuzano S. The metalloproteinase - disintegrin Kuzbanian participates in Notch activation during growth and patterning of Drosophila imaginal discs. Development. 124:1997;4769-4779.
13. Fambrough D, Pan D, Rubin GM, Goodman CS. The cell surface metalloproteinase/disintegrin Kuzbanian is required for axonal extension in Drosophila. of special interest Proc Natl Acad Sci USA. 93:1996;13233-13238 This paper shows that KUZ is required for axon extension (in addition to lateral inhibition) in Drosophila.
14. Wen C, Metzstein MM, Greenwald I. SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila kuzbanian, and its role in LIN-12/Notch signalling. of special interest Development. 124:1997;4759-4767 This paper provides the strongest indication to date for a role for an ADAM in Caenorhabditis elegans.
15. Howard L, Lu X, Mitchell S, Griffiths S, Glynn P. Molecular cloning of MADM: A catalytically active mammalian disintegrin-metalloproteinase expressed in various cell types. Biochem J. 317:1996;45-50.
16. Millichip M, Dallas D, Wu E, Dale S, McKie N. The metallodisintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Comm. 245:1998;594-598.
17. Lunn C, Fan X, Dalie B, Miller K, Zavodny P, Narula S, Lundell D. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett. 400:1997;333-335.
18. Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, Anderson L, Pyle SM, Moreland J, Meyers MA, et al. Identification and characterization of a pro-tumor necrosis factor - processing enzyme from the ADAM family of zinc metalloproteinases. of special interest J Biol Chem. 272:1997;24588-24593 The biochemical characterization and substrate specificity of human ADAM 10 are presented here.
19. Hooper NM, Karran EH, Turner AJ. Membrane protein secretases. Biochem J. 321:1997;265-279.
20. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. of outstanding interest Nature. 385:1997;729-733 The cloning of ADAM 17 and demonstration that cells lacking a functional ADAM 17 catalytic domain are deficient in releasing tumor necrosis factor α is the focus of this paper. Northern analysis and cell-surface expression of ADAM 17 are also described.
21. Moss ML, Jin S-LC, Milla ME, Burkhart W, Carter HL, Chen W-J, Clay WC, Didsbury JR, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α of outstanding interest Nature. 385:1997;733-736 The authors describe the cloning of a disintegrin metalloproteinase that processes precursor tumour necrosis factor-α. This protein, ADAM 17, was demonstrated to have proteolytic activity.
22. Aggarwal B, Natarajan K. Tumor necrosis factors: developments during the last decade. Eur Cytokine Network. 7:1996;93-124.
23. Maskos K, Fernandez-Catalan C, Huber R, Bourenkov G, Bartunik H, Ellestad G, Reddy P, Wolfson M, Rauch C, Castner B, et al. Crystal structure of the catalytic domain of human TNFa-converting enzymE. of outstanding interest Proc Natl Acad Sci USA. 95:1998;3408-3412 The first published structure of an ADAM proteinase domain, showing striking overlap of major secondary elements with a snake venom family member but also protruding loops not found in the snake venom protein.
24. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell. 63:1990;251-258.
25. Patel I, Attur M, Patel R, Stuchin S, Abagyan R, Abramson S, Amin A. TNF-α convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-α J Immunol. 160:1998;4570-4579.
26. Hooft van Huijsduijnen R. ADAM 20 and 21; two novel human testis-specific membrane metalloproteinases with similarity to fertilin-α Gene. 206:1998;273-282.
27. Yoshida S, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int Immunol. 2:1990;585-591.
28. Gilpin BJ, Loechel F, Mattei M-G, Engvall E, Albrechtsen R, Wewer UM. A novel secreted form of human ADAM 12 (meltrin α) provokes myogenesis in vivo. J Biol Chem. 273:1998;157-166.
29. Inoue D, Reid M, Lum L, Kratzschmar J, Weskamp G, Myung YM, Baron R, Blobel CP. Cloning and initial characterization of mouse meltrin β and analysis of the expression of four metalloproteinase-disintegrins in bone cells. J Biol Chem. 273:1998;4180-4187.
30. Kurisaki T, Masuda A, Osumi N, Nabeshima Y, Fujisawa-Sehara A. Spatially- and temporally-restricted expression of meltrin α (ADAM 12) and β (ADAM 19) in mouse embryo. Mech Devel. 73:1998;211-215.
31. Yagami-Hiromasa T, Sato T, Kurisaki T, Kamijo K, Nabeshima Y, Fujisawa-Sehara A. A metalloproteinase-disintegrin participating in myoblast fusion. Nature. 377:1995;652-656.
32. Alfandari D, Wolfsberg TG, White JM, DeSimone DW. ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. of special interest Dev Biol. 182:1997;314-330 This paper provides the first description of the expression pattern and proteolytic processing of an ADAM during Xenopus development.
33. Herren B, Raines EW, Ross R. Expression of a disintegrin-like protein in cultured human vascular cells and in vivo. FASEB J. 11:1997;173-180.
34. Bray S. A notch affair. of special interest Cell. 93:1998;499-503 This is the most recent report on NOTCH proteolytic processing.
35. Logeat F, Bessia C, Brou C, Le Bail O, Jarriault S, Seidah NG, Israel A. The Notch 1 receptor is cleaved constitutively by a furin-like convertase. Proc Natl Acad Sci USA. 95:1998;8108-8112.
36. Kamiguti AS, Hay CR, Zuzel M. Inhibition of collagen-induced platelet aggregation as the result of cleavage of α2β1-integrin by the snake venom metalloproteinase jararhagin. Biochem J. 320:1996;635-641.
37. Smith MR, Kung H, Durum SK, Colburn NH, Sun Y. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine. 9:1997;770-780.
38. Hargreaves PG, Wang F, Antcliff J, Murphy G, Lawry J, Russell RG, Croucher P. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloprotein inhibitor. Br J Haematol. 101:1998;694-702.
39. Armour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Khauper V, et al. TNF-α converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 1998;. in press.
40. Ehlers M, Schwager S, Scholle R, Manji G, Brandt W, Riordan J. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry. 35:1996;9549-9559.
41. Sadhukhan R, Sen G, Ramchandran R, Sen I. The distal ectodomain of angiotensin-converting enzyme regulates cleavage-secretion from the cell surface. Proc Natl Acad Sci USA. 95:1998;138-143.